IMMUNOHUB Trademark

Trademark Overview

On Thursday, December 19, 2024, a trademark application was filed for IMMUNOHUB with the United States Patent and Trademark Office. The USPTO has given the IMMUNOHUB trademark a serial number of 98913188. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, December 19, 2024. This trademark is owned by Mea mente LLC. The IMMUNOHUB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Platform that provides information on immunotherapies such as bispecific T cell engagers and chimeric antigen receptors used to treat patients.
immunohub

General Information

Serial Number98913188
Word MarkIMMUNOHUB
Filing DateThursday, December 19, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, December 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPlatform that provides information on immunotherapies such as bispecific T cell engagers and chimeric antigen receptors used to treat patients.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 19, 2024
Primary Code042
First Use Anywhere DateFriday, November 15, 2024
First Use In Commerce DateFriday, November 15, 2024

Trademark Owner History

Party NameMea mente LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10024

Trademark Events

Event DateEvent Description
Thursday, December 19, 2024NEW APPLICATION ENTERED

Related Keywords

immunohub antigen chimeric receptors used patients treat engagers cell information provides